ADIM
EVER icon

Alpha DNA Investment Management’s EverQuote EVER Stock Holding History

Alpha DNA Investment Management’s Portfolio EVER Stock Details EVER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,373
Closed -$487K – 69
2024
Q4 		$487K Buy
24,373
+3,265
+15% +$61.7K 0.19% 108
2024
Q3 		$445K Sell
21,108
-1,875
-8% -$42.8K 0.17% 147
2024
Q2 		$479K Sell
22,983
-4,172
-15% -$88.2K 0.19% 117
2024
Q1 		$504K Buy
+27,155
New +$399K 0.19% 150

Other funds holding EVER

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alpha DNA Investment Management's EVER Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of EverQuote (EVER) in Q1 2025, closing a stake of 24,373 shares — an estimated $487K sold.

Alpha DNA Investment Management first reported a position in EVER in Q1 2024 and held it in 4 quarters. The position peaked at $504K in Q1 2024. 216 funds tracked by Wall St. Rank hold EVER as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining EverQuote position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 24,373 EverQuote shares in Q1 2025, an estimated $487K.
  • Alpha DNA Investment Management first reported a position in EverQuote in Q1 2024 and held it in 4 quarters.
  • Alpha DNA Investment Management's EverQuote position peaked at $504K in Q1 2024.
  • 216 funds tracked by Wall St. Rank held EverQuote as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.